4//SEC Filing
WEIL JOHN D 4
Accession 0001638599-19-000957
CIK 0000874710other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 11:26 AM ET
Size
23.4 KB
Accession
0001638599-19-000957
Insider Transaction Report
Form 4
WEIL JOHN D
Director10% Owner
Transactions
- Award
Option to purchase common stock
2019-11-07+750→ 750 totalExercise: $1.17From: 2020-11-07Exp: 2029-11-07→ Common stock (750 underlying)
Holdings
- 750
Option to purchase common stock
Exercise: $4.62From: 2014-11-14Exp: 2023-11-14→ Common stock (750 underlying) - 90,513
Common Stock
- 2,500(indirect: By IRA)
Common Stock
- 7,927(indirect: Corporation)
Common Stock
- 750
Option to purchase common stock
Exercise: $2.22From: 2018-11-09Exp: 2027-11-09→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $2.34From: 2016-11-12Exp: 2025-11-12→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $7.10From: 2012-11-10Exp: 2021-11-10→ Common stock (750 underlying) - 60,520(indirect: By Trust)
Common Stock
- 94,427(indirect: By Spouse)
Common Stock
- 59,101(indirect: By Trust)
Common Stock
- 137,736(indirect: By Partnership)
Common Stock
- 750
Option to purchase common stock
Exercise: $3.16From: 2015-11-13Exp: 2024-11-13→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $8.68From: 2011-11-11Exp: 2020-11-11→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $10.08From: 2010-11-13Exp: 2019-11-13→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $2.13From: 2019-11-08Exp: 2028-11-08→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $2.26From: 2017-11-10Exp: 2026-11-10→ Common stock (750 underlying) - 750
Option to purchase common stock
Exercise: $5.18From: 2013-11-08Exp: 2022-11-08→ Common stock (750 underlying)
Footnotes (6)
- [F1]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economical benefit in such shares.
- [F2]The reporting person disclaims any economic benefit in such shares.
- [F3]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
- [F4]Owned by a corporation controlled by the reporting person.
- [F5]Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
- [F6]Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
Documents
Issuer
ALLIED HEALTHCARE PRODUCTS INC
CIK 0000874710
Entity typeother
IncorporatedMO
Related Parties
1- filerCIK 0000904314
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 11:26 AM ET
- Size
- 23.4 KB